Search - SmartMoney.com

WSJ
- WSJ
MarketWatch
- MarketWatch
Barrons
- Barrons
SmartMoney
All Things Digital
- All Things Digital
Financial Jobs
- Financial Jobs
Factiva
- Factiva
More
- BigCharts
- Virtual Stock Exchange
- WSJ Asia
- WSJ Europe
- WSJ Americas
  - en Español
  - em Português
- WSJ Classifieds
- WSJ Radio
- WSJ Wine

7 Days 30 Days 90 Days 2 Years Range: Select a Date Range

SmartMoney
The Wall Street Journal
MarketWatch
Barron's

News Results (1-15 of 575)

Sort by:Relevance Date

Perrigo's top brass to make presentations on the East and West Coasts WSJM

ALLEGAN, MI – Perrigo Co.’s top brass will be busy making presentations in early June. Joseph C. Papa, chairman, president and chief executive officer of the store-brand pharmaceuticals maker, is scheduled to present at the Jefferies Global ...
Japan's Takeda Strikes Brazil Drug Deal WSJ Blogs

Following last month's acquisition of Philadelphia-based URL Pharma Inc., Japan's Takeda Pharmaceutical has struck another deal, this time in Brazil. Takeda's overseas acquisitions now total almost $15 billion in the last two years, ...
PIMCO Total Return, Alexion Pharmaceuticals: Money Flow Leaders (BOND, ALXN) WSJ.com

PIMCO Total Return ETF topped the list in late trading for Buying on Weakness , which tracks stocks that fell in price but had the largest inflow of money. See the full list .
Stocks to Watch: Frontline, VeriFone Systems, Talbots WSJ Blogs

By Corrie Driebusch and Nathalie Tadena Among the companies with shares expected to actively trade in Friday's session are Frontline Ltd. (FRO), VeriFone Systems Inc. (PAY) and Talbots Inc. (TLB).
Subscriber Content Read Preview

Drug Plan Draws Fire in India; Pharmaceutical Makers Resist Government's Effort to Control Costs of Larger Number of Medicines WSJ.com

BANGALORE, India—India's government is facing stiff resistance from foreign and domestic pharmaceutical companies over its plan to limit prices for drugs severely.
Subscriber Content Read Preview

EU Joins Widening Push to Find New Antibiotics WSJ.com

LONDON—The European Union Thursday pledged funds to find new antiobiotics, its first attempt to help drugmakers develop medicines to fight increasingly drug-resistant superbugs that are taking more lives every year and adding to rising ...
New Approach Needed in Search for Antibiotics WSJ Blogs

Europe's tentative step towards addressing the screaming need for new antibiotics, while laudable, smacks of "too little, too late." Excessive overuse of existing antibiotics and a lack of research and development into finding new ones means ...
India’s pharma, consumer stocks shine MarketWatch

MUMBAI (MarketWatch) – While Indian stocks are among the worst performers among Asian peers this year, the pharmaceutical and consumer discretionary sectors have been booming since March.
Stocks to Watch: J.P. Morgan, McDermott, Arena Pharmaceuticals WSJ Blogs

By Corrie Driebusch, Mia Lamar and Drew FitzGerald Among the companies with shares expected to actively trade in Friday's session are J.P. Morgan Chase & Co. (JPM), McDermott International Inc. (MDR) and Arena Pharmaceuticals Inc. ...
Another Pharmaceutical Deal Goes Down WSJ Blogs

Pharmaceuticals are getting swallowed up left and right. This evening after the close, Jazz Pharmaceuticals announced it would pay as much as $700 million in cash for EUSA Pharma Inc., a privately held company with a leukemia treatment.
Subscriber Content Read Preview

Senate Easily Approves Bill on Drug Reviews WSJ.com

The Senate voted Thursday to expand the number of drug companies that must pay the Food and Drug Administration to review new products and gave the agency new powers to regulate drug supplies.
Subscriber Content Read Preview

Report Faults Doctors; Long Island Grand Jury Blames Physicians, Pharmacists for Epidemic of Abuse WSJ.com

HAUPPAUGE, N.Y.—Revealing the results of a special grand jury investigation, Suffolk County District Attorney Thomas Spota on Thursday blamed physicians and pharmacists for an epidemic of prescription-drug addiction in the past decade.
Canadian stocks edge up as commodities rebound MarketWatch

SAN FRANCISCO (MarketWatch) — Canadian stocks closed fractionally higher on Thursday as commodities recovered from recent losses. But anxiety over whether Greece will stay in the euro zone kept some investors on the sidelines.
Lessons From One Genetic Disorder Raise Hopes for Treating Another, Rarer One WSJ Blogs

If you haven't heard of Stargardt disease, it's not because it isn't serious. The condition results in blindness, there's no approved treatment and there are few options for delaying the damage it progressively wreaks. But it only afflicts 1 ...
Subscriber Content Read Preview

Shanghai Fosun Pharmaceutical's IPO Gets OK WSJ.com

HONG KONG—Shanghai Fosun Pharmaceutical (Group) Co., a unit of conglomerate Fosun International Ltd., has received Hong Kong regulatory approval for its up to $800 million Hong Kong initial public offering, a person familiar with the ...

1-15 of 575

Answer Engine
Find Answers to Life's Challenges

Am I saving enough for retirement?

Find solutions to this and many other problems using

Answer Engine from SmartMoney.

From the Magazine

10 Things
10 Things Hollywood Won't Tell You
Now playing: sequels, 3-D reruns and long ads.
Wedding Crashers: Saying 'I Do' in Public
Need an alternative to the $25,000 to-do? Introducing the stealth approach, where couples quietly trade "I dos" in a host of public forums.
The Reignited Tech Sector
Technology stocks have rebounded and are once again the darling of the market. Can the resurgence last?
Why a 'Balanced' Portfolio May Not Work
Arends: That 60/40 portfolio of stocks and bonds your adviser is pushing might not work.

SmartMoney

Account Services:

Help & Information Center:

About:

SmartMoney.com:

Tools & Formats:

The Wall Street Journal Digital Network:

Foreign language editions:

Intraday Data provided by SIX Telekurs and subject to terms of use. Historical and current end-of-day data provided by SIX Telekurs. Fundamental Data provided by Factset. Mutual Fund and ETF Data provided by Lipper. Intraday data delayed per exchange requirements. Dow Jones Indexes (SM) from Dow Jones & Company, Inc. All quotes are in local exchange time. Real time last sale data provided by NASDAQ only. Comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Mutual Fund and ETF NAVs are as of previous day's close.

SmartMoney - The Wall Street Journal

top stories in News Reel

Investor Center

My SmartMoney

Columns & Blogs

Tools

Columns & Blogs

Tools

Tools

Columns & Blogs

Tools

Columns & Blogs

Tools

Columns & Blogs

Tools

Featured Tools

Video Results ( of )

Opinion: Who Really Owns the Oil Co... 5:25

Aviva CEO Leaves Amid Shareholder P... 2:29

Smuggled Pills From China Made of H... 3:08

Roche CEO on Illumina, DNA Sequenci... 18:13

Goldman Sachs Insider Probe Widens 4:01

Astra Zeneca CEO to Leave Following... 3:10

Why M&A Has Returned to the Pharmac... 3:32

Opinion: Christie's Pilgrimage to J... 5:34

Building Pharma with M&A, not R&D 1:50

Avon Names J&J's Sheri McCoy as CEO 3:31

Post Crisis, Big Firms Come Back St... 4:23

How to Follow Health Care Stocks in... 2:00

AstraZeneca Fails to Stop Generic R... 3:03

Roche Cuts Cost of Cancer Drugs in ... 2:53

Opinion: The ObamaCare Death Spiral 3:38

Answer Engine Find Answers to Life's Challenges

10 Things

SmartMoney

Account Services:

Help & Information Center:

About:

SmartMoney.com:

Tools & Formats:

The Wall Street Journal Digital Network:

Foreign language editions:

Answer Engine
Find Answers to Life's Challenges